RhabdomYolyse in Intensive caRe
NCT06101680 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2023-10-26
Summary
Analysis of the outcome of patients \< 18 years old, treated in an intensive care unit for severe rhabdomyolysis, regardless of etiology (renal failure rate, death rate, organ replacement rate)
Conditions
- Rhabdomyolysis
Sponsors & Collaborators
-
Central Hospital, Nancy, France
lead OTHER
Principal Investigators
-
Arnaud Wiedemann, MD PhD · CHRU Nancy
Eligibility
- Min Age
- 0 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-10-01
- Primary Completion
- 2023-12-01
- Completion
- 2024-01-01
Countries
- France
Study Locations
More Related Trials
-
Dexamethasone Use in Pediatric Rhabdomyolysis Patients in Addition to Standard Protocols
NCT06429982 ·Status: RECRUITING ·Phase: PHASE1
-
A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB
NCT03530852 ·Status: RECRUITING ·Phase: NA
-
Study to Assess Efficacy and Safety of Lanreotide Autogel 120 MG in Treatment of Clinical Symptoms Associated With Inoperable Malignant Intestinal Obstruction
NCT02275338 ·Status: COMPLETED ·Phase: PHASE2
-
13C Trioctanoate Breath Test as a Measurement of Gastric Fat Volume Emptying
NCT02602158 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Safety and Tolerance Study of Recombinant Human Albumin Injection in Healthy Subjects.
NCT04641364 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment Study of the Effect of NMBA on Bowel Peristalsis
NCT02004015 ·Status: TERMINATED ·Phase: PHASE4
-
Hydrocortisone Use After Etomidate in Intensive Care
NCT00862381 ·Status: COMPLETED ·Phase: PHASE3
-
Nutritional Tolerance and Safety of a Tube Feeding Formula
NCT05848583 ·Status: TERMINATED ·Phase: NA
-
Hydrocortisone and Fludrocortisone for Critical Illness-related Corticosteroid Insufficiency
NCT04404400 ·Status: RECRUITING ·Phase: PHASE3
-
Reevaluation Of Systemic Early Neuromuscular Blockade
NCT02509078 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Study of HepaStem for the Treatment of Urea Cycle Disorders (UCD) and Crigler-Najjar Syndrome (CN)
NCT01765283 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Serial Amnioinfusions as Regenerative Therapy for Pulmonary Hypoplasia
NCT03723564 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants With Symptomatic Diabetic or Idiopathic Gastroparesis
NCT04303195 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study of Glycerol Phenylbutyrate in Chinese Patients With Urea Cycle Disorders
NCT06904027 ·Status: RECRUITING
-
Risk Stratification and Heterogeneity for Organ Damage in Acute Diquat Poisoning
NCT06798142 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of FDY-5301 in Major Trauma Patients in ICU
NCT04430283 ·Status: TERMINATED ·Phase: PHASE2
-
A Protocol to Allow Treatment With ICL670 for Patients With or at Risk of Life-threatening Complications of Transfusional Iron Overload Who Are Unable to Tolerate Other Iron Chelators Because of Documented Severe Toxicity
NCT01044186 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Oxytocin on the Gastric Emptying
NCT00776360 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Succinylcholine Versus Rocuronium for Emergency Intubation in Intensive Care
NCT00355368 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess Safety and Efficacy of sc Pasireotide in Patients With Dumping Syndrome
NCT01895296 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Neuromuscular Blocking Agents (NMBA) on the Alteration of Transpulmonary Pressures at the Early Phase of Acute Respiratory Distress Syndrome (ARDS)
NCT01573715 ·Status: UNKNOWN ·Phase: PHASE4
-
Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade at the End of Kidney Transplantation Surgery
NCT03923556 ·Status: COMPLETED ·Phase: PHASE4
-
L-citrulline for Prevention of Sequelae of Acute Lung Injury in Pediatrics Undergoing Cardiopulmonary Bypass for Heart Defects
NCT02891837 ·Status: COMPLETED ·Phase: PHASE3
-
Anabolic Steroids for Nutritional Rehabilitation of Critically Ill Patients
NCT00242463 ·Status: TERMINATED ·Phase: PHASE2
-
Neuromuscular-Blocking Agents and Hypoxemia During Intubation in Infants (ROC-HYPOX)
NCT02589691 ·Status: RECRUITING ·Phase: PHASE4